VDJ-006

N/A

Report date: 2025/07/21 14:21:37

Base Information

Drug NameVDJ-006
Drug Alias Namelong-acting IL-1-R1 antagonist (Beijing VJDBio)VDJ-006
ClassificationBiologics
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsDermatitis, AtopicCryopyrin-Associated Periodic SyndromesArthritis, Gouty +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Vdjbio Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Vdjbio Co Ltd
Inactive CompaniesN/A
Active IndicationsDermatitis, AtopicCryopyrin-Associated Periodic SyndromesArthritis, Gouty +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A